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Background: Long QT syndrome (LQTS) is associated with increased risk of ventricular arrhythmias and cardiac
arrest. LQTS type 1 (LQT1), the most prevalent subtype of LQTS, is caused by defects of slow delayed rectiﬁer po-
tassium current (IKs) that lead to abnormal cardiac repolarization. Here we used pluripotent stem cell (iPSC)-
technology to investigate both the electrophysiological and also for the ﬁrst time themechanical beating behav-
ior of genetically deﬁned, LQT1 speciﬁc cardiomyocytes (CMs) carrying different mutations.
Methods:We established in vitromodels for LQT1 caused by twomutations (G589D or ivs7-2ANG). LQT1 speciﬁc
CMswere derived from patient speciﬁc iPSCs and characterized for their electrophysiology using a current clamp
and Ca2+-imaging. Their mechanical beating characteristics were analyzed with video-image analysis method.
Results and conclusions: Both LQT1-CM-types showed prolonged repolarization, but only those with G589D pre-
sented early after-depolarizations at baseline. Increased amounts of abnormal Ca2+ transients were detected in
both types of LQT1-CMs. Surprisingly, also the mechanical beating behavior demonstrated clear abnormalities
and additionally the abnormalities were different with the two mutations: prolonged contraction was seen in
G589D-CMs while impaired relaxation was observed in ivs7-2ANG-CMs.
The CMs carrying two different LQT1 speciﬁc mutations (G589D or ivs7-2ANG) presented clear differences in
their electrical properties as well as in their mechanical beating behavior. Results from different methods corre-
lated well with each other suggesting that simplymechanical beating behavior of CMs could be used for screen-
ing of diseased CMs and possibly for diagnostic purposes in the future.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Long QT syndrome (LQTS) is an electric disorder of the heart that
predisposes patients to arrhythmias and sudden cardiac death. The ar-
rhythmias related to LQTS are distinctive ventricular arrhythmias called
Torsades de Pointes (TdP) [1]. LQTS type 1 (LQT1) is themost prevalent
subtype of the disease. It is caused by mutations in KCNQ1 gene
encoding theα-subunit of the channel responsible for the slow compo-
nent of the delayed rectiﬁer potassium current (IKs) [2,3]. The inade-
quate IKs current leads to prolongation of repolarization time of action
potentials (APs) in single CMs and to prolonged QT interval seen inniversity of Tampere, Finland.
eliability and freedom from bias
land Ltd. This is an open access articelectrocardiogram (ECG). Various mutations in KCNQ1 have been iden-
tiﬁed to cause LQT1 possibly with varying clinical phenotypes [4,5].
Currently different LQTS subtypes are diagnosed with gene muta-
tions in particular genes. However, there is a huge spectrum of muta-
tions in each gene and the severity of the disease has been observed
to be more dramatic due to mutations in some genetic regions
compared to others [4,6]. Also in cell culture studies with transfected
cells, different mutations in the same gene have had different effects
on the electrical properties of the cells [7,8]. While some mutations
(e.g. G589D) seem to have rather mild and recessive effect on the IKs
current [8], other mutations (e.g. ivs7-2ANG) cause a complete loss-of-
function of the IKs channel in a dominant negative fashion [7]. Little is
known about the mechanisms of the ivs7-2ANG to cause the loss-of-
function effect on IKs current while G589D mutation seems to be a
clear trafﬁcking mutation with normal functioning of the channel but
with hindered transportation to the plasma membrane [9].
With induced pluripotent stem cell (iPSC) technology, it is possible
to generate genetically deﬁned stem cell lines [10,11] and differentiatele under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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be generated and studied in vitro [12–18]. Traditionally the functionality
of CMs in cell culture is determined by electrical or optical analysis, such
as patch clamp-technique and microelectrode array (MEA) or calcium
(Ca2+)-imaging and voltage sensitive probes. However, all these
methods have some limitations. Patch clamp-technique is time con-
suming as well as invasive and cells die after measurements. Voltage
sensitive dyes and the tracers used in Ca2+-imaging may alter the elec-
trophysiological properties of CMs and the cells may also be damaged
by photo-toxicity [19] or compartmentalization [20] and cells die after
analysis. MEA can efﬁciently be used for cell clusters but due to the
physical dimensions of the electrodes and limitations in the sensitivity,
it is not suitable with single cells. In addition, thesemethods detect only
ion ﬂuxes that obviously are important but some other, currently even
unknown factors inﬂuencing the beating of CMs may be neglected.
The analysis of mechanical beating properties could reveal additional
information beyond the electrical phenomena and this analysis is nei-
ther invasive nor toxic and cells can be monitored for a long time.
In this study we present the electromechanical properties of LQT1-
CMs having different mutations in the KCNQ1 gene (G589D or ivs7-
2ANG). The electrical andmechanical behavior of the cells was analyzed
using a single cell current clamp, Ca2+-imaging and light microscopy
video-image analysis. CMs with either of the LQT1-genotypes had sig-
niﬁcantly prolonged APs, but only CMswith G589Dmutation had spon-
taneous early afterdepolarizations (EADs) at baseline. Additionally, also
abnormal Ca2+ transientswere observed in LQT1-CMs.We also demon-
strate that the mechanical beating behavior of the CMs with different
KCNQ1 genotypes has distinct mutation-speciﬁc features. This is the
ﬁrst published work where mechanical beating properties of LQTS are
studied at the single cell level and theﬁrst evidence that LQTS can be de-
tected by monitoring the mechanical beating of the cells.
2. Methods
The studywas approvedby the ethical committee of PirkanmaaHos-
pital District (R08070) andwritten consent was obtained from all ﬁbro-
blast donors.
2.1. Clinical information
LQT1 patient carrying G589D mutation is a 46-year-old female with
corrected QT interval (QTc) of 464ms. She has been suffering from syn-
copal spells. The other LQT1 patient is a 51-year-old female carrying
ivs7-2ANG in KCNQ1. She has suffered from dizziness, darkening of
vision and episodes of unconsciousness. Her QTc is 489 ms. Both of
these patient are on β-blocker medication. Control iPSCs were generat-
ed from a healthy female, 55 years of age with QTc of 406 ms. The pa-
tients with LQT1 were on beta blockers and no irregularities in the
QTc were found in the resting condition (Fig. 3 A–C).
2.2. Cell culture conditions
Primary ﬁbroblasts from the skin biopsy were cultured under ﬁbro-
blast culturing conditions using Dulbecco's modiﬁed Eagle medium
(DMEM, Lonza, Basel, Switzerland) with 10% FBS (Lonza), 2 mM
glutamax (Life Technologies Ltd, Paisley, UK) and 50 U/ml penicillin/
streptomycin (Lonza). 293FT-cells (Life Technologies Ltd) were cul-
tured in the same conditions with 1% nonessential amino acids (NEAA,
Cambrex, East Rutherford, NJ, USA). Plat-E-cells (Cell Biolabs, San
Diego, CA, USA) and irradiated/mitomycin C (Sigma-Aldrich, St. Louis,
MO, USA) treated mouse embryonic ﬁbroblasts (MEF) (Millipore,
Billerica, MA, USA) were maintained similarly but without antibiotics.
iPSCs were sustained together with MEF feeder cells in KSR-medium
containing knockout (KO)-DMEM (Life Technologies Ltd), 20% KO-
serum replacement (KO-SR, Life Technologies Ltd), NEAA, glutamax,
penicillin/streptomycin, 0.1 mM β-mercaptoethanol (Life TechnologiesLtd), and 4 ng/ml basic ﬁbroblast growth factor (bFGF, R&D Systems
Inc., Minneapolis, MN, USA). All the cells were grown at 37 °C and 5%
CO2 and the medium was changed every other day for iPSCs and two
times a week for all the other cells.
2.3. Generation and characterization of iPSC lines
The LQT1 patients carried either the G589D mutation of KCNQ1
(KCNQ1-FinA) or the ivs7-2ANG mutation in KCNQ1 (KCNQ1-FinB)
[21]. Skin biopsies from the donors were cultured in 0.2% gelatin
(Sigma-Aldrich)-coated ﬂasks under ﬁbroblast culturing conditions.
iPSC lines were established using lentivirus infection followed by retro-
virus infection. The full protocol has been described by Takahashi and
colleagues[10]. Cells, plasmids and reagents used in this protocol in-
clude: 293FT cells, Plat-E cells, pLenti6/UbC/mSlc7a1-vector (Addgene,
Cambridge, MA, USA), ViraPower™ Packaging Mix (Life Technologies
Ltd), Lipofectamine™ 2000 (Life Technologies Ltd), Fugene 6 (Roche Di-
agnostics, Mannheim, Germany), and pMX retroviral vectors (hOCT3/4,
hSOX2, hKLF4 and hc-MYC, all from Addgene). Several lines were
established from both patients and from control individual and two
from each were selected for further characterization. Studied cell lines
were UTA.00208.LQT1 and UTA.00211.LQT1 generated from KCNQ1
patient with G589D mutation, UTA.00102.LQT1 and UTA.00118.LQT1
generated from KCNQ1 patient with ivs7-2ANG mutation, and
UTA.04602.WT and UTA.04607.WT generated from healthy control
individuals.
Characterization of control iPSC lines is described in detail by Ahola
and colleagues [22]. LQT1 speciﬁc iPSCs were characterized similarly
by RT-PCR, immunocytochemistry, embryoid body (EB) and teratoma
formation. Teratomas were generated from one control iPSC line
(UTA.04602.WT) and two LQT1-lines one carrying G589D mutation
and the other ivs7-2ANG in KCNQ1. In addition, the karyotypes of all
the lines were analyzed. The lines were also assayed with PCR and re-
striction reactions to detect the correctmutations ofKCNQ1 from the ge-
nomic DNA and the control iPSC line was veriﬁed not to carry these
mutations. DNA was isolated using DNA Tissue XS-kit (Macherey-
Nagel GmbH & Co., Düren, Germany) and multiplied with AmpliTaq
360 Polymerase (Life Technologies Ltd) with 100 ng of template,
2 mM of MgCl2, 200 μM of NTPs, 0.5 μM of primers (G589D forward:
ttg act ctc agc tac ctc cc, reverse: tgc agg agc ttc acg ttc ac, ivs7-2ANG for-
ward: ggg gag ctg tag ctt cca ta, reverse: agc caa atg cat ggt gag at,
Biomers.net GmbH, Ulm, Germany), and 1 U/ μl of enzyme in total vol-
ume of 40 μl. Reaction conditions: 96 °C for 10min (96 °C for 30 s, 60 °C
for 30 s, 72 °C for 2min), 35 cycles, 72 °C for 5min. Digestion for KCNQ1-
G589D was done with HIN6I (Thermo Fisher Scientiﬁc, Inc., Waltham,
MA, USA) with Tango Buffer (Thermo Fisher Scientiﬁc, Inc.), and for
KCNQ1-ivs7-2ANG with Dde1 (Thermo Fisher Scientiﬁc, Inc.) using
FastDigest Buffer (Thermo Fisher Scientiﬁc, Inc.) both with 10 μl from
PCR in total volume of 20 μl at 37 °C over night. Products were run on
4% agarose gel (EuroClone S.p.A., Milano, Italy): wild type (WT) for
G589D (G589D-WT) generates product sizes 146, 82 and 39 bp, hetero-
zygote (Hez) for G589D (G589D-Hez) generates an extra fragment of
185 bp, ivs7-2ANG-WT produces sizes 228, 39 and 33 bp and ivs7-
2ANG-Hez an extra product with size of 261 bp. Extra fragments are
caused by vanishing of the cleavage sites due to the mutations
(G589D: 146 + 39 = 185, ivs7-2ANG: 228 + 33 = 261) (Fig. 2).
2.4. Cardiac differentiation and immunocytochemical characterization
of CMs
CM differentiation was accomplished by co-culturing iPSCs with
END-2 cells (a gift from Prof. Mummery, Humbrecht Institute, Utrecht,
The Netherlands). END-2 cells were cultured as described byMummery
and colleagues [23]. Differentiation was initiated by dissecting the un-
differentiated iPSC colonies mechanically into aggregates containing
a few hundred cells. These cells were then plated onto mitomycin
21A.L. Kiviaho et al. / IJC Heart & Vasculature 8 (2015) 19–31C-treated END-2 cells in KSR medium without serum, serum replace-
ment, or basic ﬁbroblast growth factor but with 2.92 mg/ml of ascorbic
acid [4] (Sigma-Aldrich). The cell colonies were monitored daily by mi-
croscopy, and the medium was changed after 5, 8, and 12 days. After
14 days of culturing, 10% serum replacement was added to the ascorbic
acid free medium.
For immunocytochemical staining the beating areas of the cell
colonies were cut with a scalpel and treated with collagenase A
(Roche Diagnostics, Mannheim, Germany). Dissociated cells were
plated on 0.1% gelatin-coated 24-well platewells in KO-DMEM contain-
ing 20% FBS. A maximum of seven days after dissociation, beating cells
were ﬁxed with 4% paraformaldehyde (PFA, Sigma-Aldrich) for immu-
nostaining with cardiac markers: anti-cardiac-troponin-T (1:1500,
Abcam, Cambridge, MA, USA), anti-α-actinin (1:1500, Sigma-Aldrich),
anti-myosin-heavy-chain (MHC, 1:100, Millipore), anti-ventricular-
myosin-light-chain (MLC2v, 1:150, Abcam) and anti-atrial-myosin-
light-chain (MLC2a, 1:300, Abcam). The secondary antibodies were
Alexa-Fluor-568-donkey-anti-goat-IgG, Alexa-Fluor-568-goat-anti-
mouse-IgG, Alexa-Fluor-488-donkey-anti-rabbit-IgG, and Alexa-Fluor-
488-donkey-anti-mouse-IgG (all 1:800, all from Life Technologies Ltd).
2.5. Video recording
For the video recordings CMaggregateswere dissociated in the same
way as for immunocytochemical analysis (see above). Videos were re-
corded within a week from dissociation using video microscopy
(Nikon Eclipse TS100, Nikon Corporation, Tokyo, Japan) with a video
camera Optika DIGI-12 (Optika Microscopes, Ponteranica, Italy). 30–
60 second long monochrome videos were recorded with 720 × 480
resolution and 30 frames per second. Beatingwas determined as normal
if the rhythm was regular and the phases of contraction and relaxation
followed each other without any delay or additional movement of the
cell. Any deviation from that was considered as abnormal beating.
2.6. Beating analysis
In total 58 videos (13 controls, 24 LQT1-G589D (FinA)-speciﬁc and
25 LQT1-ivs7-2ANG (FinB)-speciﬁc) were analyzed using digital image
correlation (DIC) based analysis method, as described by Ahola et al.
[22]. In brief, the velocity vector ﬁelds representing video image gray
level changes in pixel level were calculated from subsequent video
frames using a minimum quadratic difference based DIC method. For
each CM, the beating focus point was visually determined and the CM
was divided into 8 sectors, each comprising of 45° sector, around the
beating focus point. With each selection, motion towards the beating
focus point was determined as radial, and perpendicular motion as tan-
gential movement. The sum radial and tangential components were
computed for each sector.
Out of the 16 possible signals obtained from a CM 3 signals were se-
lected based on the signal quality. From these signals the average pa-
rameters of beating were deﬁned: (1) duration of the contraction,
(2) timewhen contracted, (3) duration of the relaxation, (4) incomplete
relaxation time and (5) time when relaxed.
2.7. Allelic imbalance
Allelic discrimination between theWT andmutated KCNQ1 alleles in
CMs derived from different iPSC lines was done by qPCR using standard
curves. In order to establish a KCNQ1 allelic standard curves, the plasmid
with WT KCNQ1 and the plasmid containing the mutant allele were
combined with following ratios: 1:0, 8:1, 4:1, 2:1, 1:1, 1:2, 1:4, 1:8
and 0:1, respectively, for the qPCR reactions [12]. The standard curves
were done similarly for both mutations (G589D and ivs7-2ANG) ad-
dressed in this study. Plasmids used for the curve preparation were
pBluescript SK+ plasmids (Addgene) with the inserted gene at the
BamHI/NotI-site. The standard curves were plotted log2 of WT/mutantratios of plasmids versus corresponding ΔCt values. The ΔCt values
were deﬁned by subtracting Ct value of WT allele from Ct value of the
allele with the mutation. In standard curves, ΔCt values for plasmid ra-
tios are represented in statistical form of mean ± standard deviation
(n = 3) [18].
In addition,ΔCt values were deﬁned for KCNQ1mutations and those
were used for locate spots of KCNQ1 mutated samples on plasmid-
derived standard curves. The location of spot deﬁnes allelic imbalance
of mutation when compared to nearby plasmid ratios.
To determine the allelic imbalance of KCNQ1 in CMs originated from
different mutation speciﬁc cell lines (UTA.00208.LQT1with G589D, and
UTA.00118.LQT1 containing ivs7-2ANG) the clusters of beating areas
were ﬁrst cut using a scalpel and total RNA was puriﬁed from the cell
clusters with a NucleoSpin® RNA II Kit (Macherey-Nagel GmbH & Co.)
according to the manufacturer's protocol. The isolated RNA was con-
verted into cDNAs using a High Capacity cDNA Reverse Transcription
Kit (Life Technologies Ltd). For allelic discrimination the primers and
probes were designed by Custom TaqMan® SNP Genotyping Assay ser-
vice (Life Technologies Ltd). qPCR reactions were done using 7.5 μl 2×
TaqMan® Universal PCR Master Mix, 0.375 μl Custom TaqMan® SNP
Genotyping Assay, and 2.125 μl sterile water with total volumes of
12 μl and 3 μl of cDNA or plasmid DNA added into the reaction. The pro-
gram was initiated with 2 min at 50 °C and 10 min at 95 °C following
40 cycles of 15 s at 95 °C and 1 min at 60 °C.
2.8. Current clamp-measurements
2.8.1. Potassium channel blockers
Rapid delayed rectifying potassium (IKr or hERG) channel blocker, N-
[4-[[1-[2-(6-methyl-2-pyridinyl)ethyl]-4-piperidinyl]carbonyl]phenyl]
methanesulfonamide dihydrochloride (E-4031 [24] Sigma-Aldrich)was
dissolved in H2O (stock 2.11 mM) and stored at−20 °C. IKs blocker, 2-
(4-chlorophenoxy)-2-methyl-N-[5 [(methylsulfonyl)amino]tricyclo
[3.3.1.13,7]dec-2-yl]-propanamide (JNJ303 [25] Tocris Bioscience,
Bristol, United Kingdom) was dissolved in DMSO (stock 25 mM) and
stored at −20 °C. Experimental HEPES based perfusate with E-4031
and JNJ303 was freshly prepared on the day of use by dissolving the
stocks to ﬁnal concentrations of 100 nM and 300 nM (DMSO 0.03%), re-
spectively. Action potentials (APs) were unaffected by a 0.03% DMSO
vehicle tested in 5/5 CMs.
2.8.2. Measurement of action potentials
APs were recorded from spontaneously beating CMs in current-
clamp mode using the perforated patch conﬁguration [26] The HEPES
based extracellular perfusate consisted of (in mM): 143 NaCl, 4.8 KCl,
1.8 CaCl2, 1.2 MgCl2, 5 glucose, and 10 HEPES, pH was adjusted to 7.4
with NaOH (at room temperature) and the osmolarity set to 308 ±
2 mOsm with sucrose (Gonotec, Osmomat 030, Labo Line Oy, Helsinki,
Finland). The intracellular solution consisted of (in mM): 122 KMeSO4,
30 KCl, 1 MgCl2, and 10 HEPES. KOH was used to set pH to 7.15 and
the osmolarity was set to 302 ± 2 mOsm. Amphotericin B (Sigma-Al-
drich) was used as a membrane perforation agent and dissolved in
DMSO to a ﬁnal concentration in the patch pipette of 0.24mg/ml. Disso-
ciation of the spontaneously beating CMs was done similarly as for im-
munocytochemical staining and for video recordings but the cells were
plated onto 0.1% gelatin-coated cover glasses of 5mm⌀ for patch clamp-
measurements. The CMs were recorded on days 6–7 after plating.
Coverglasses with CMs were fast transferred to a preheated 36 ± 1 °C
fast RC-24N perfusion chamber (Warner Instruments LLC, Hamden,
CT, USA). An SH-27B inline heater (Warner Instruments LLC) was used
to preheat the perfusate. Cells were rested in the extracellular perfusate
for more than 10 min prior to patching. Patch electrodes (model
PG150T, Harvard Apparatus, Holliston, MA, USA) were pulled with a
PC-10 puller (Narishige International Limited, London, UK) and ﬂame
polished with microforge MF-900 (Narishige International Limited) to
a resistance of 3.0–3.5 MΩ measured in the bath perfusate. Drugs
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entiﬁc Instruments, Farmingdale, NY, USA). APs were recorded in gap-
free modewith pClamp 10.2 using the Axopatch 200B patch clamp am-
pliﬁer connected to an acquisition computer via AD/DA Digidata 1440
(Molecular devices LLC). Current-clamp recordings were digitally sam-
pled at 20 kHz and ﬁltered at 5 kHz using the low pass Bessel ﬁlter on
the recording ampliﬁer. Numbers of CMs measured (n) are presented
in the Tables 2A and 2B, and Tables 3A and 3B.
2.8.3. Extraction of action potential characteristics
Following stabilization of the spontaneously generated APs in
current-clampmode, a baseline of minimum of 2 min was acquired be-
fore drug application. Gap-free traces of individual CM recordings were
then imported intoMicrocal Origin™ 8.6 or 9.0 and processed by an au-
tomated script. Beats per minute (BPM), AP duration at 50% and 90% of
repolarization (APD50 and APD90), AP amplitude (APA), and maximum
diastolic potential (MDP) were extracted. dV/dT (Vmax, maximal up-
stroke velocity) was extracted from the differentiated time course
traces as peak values corresponding to each single AP. Single AP charac-
teristics were then plotted as a function of time for evaluation and a se-
ries of minimum of 15 APs were averaged for each CM and used in the
statistical analysis. Ventricular-like CMs were deﬁned by APD90/
APD50 b 1.3 and APAN95 mV, atrial-like by APD90/APD50 N 1.3 and
APAN95 mV and ﬁnally nodal-like were deﬁned by APD90/APD50 N 1.3
and APA b 95 mV.
2.9. Combined current clamp-measurements and video analysis
APs from a CM of each cell line (control, G589D and ivs7-2ANG)
were recorded using a current clamp. During the current clamp-
measurement, a concurrent video was recorded using an inverted IX71
microscope (Olympus Corporation, Hamburg, Germany) and an
ANDOR iXon 885 CCD camera (Andor Technology, Belfast, Northern
Ireland). The video recordings were then analyzed using the previously
described method [22]. A good quality beating motion signal was select-
ed, and theAP and themotion signal for each cell linewere synchronized.
2.10. Calcium imaging
CMs were dissociated as described in the section about immunocy-
tochemical staining and plated onto 0.1% gelatin-coated 13 mm cover
slips. 6–8 days after dissociation the cells were loaded with 4 μM Fura-
2 AM (Life Technologies Ltd) for 30 min in HEPES based medium at
37 °C. After incubation the cover slips were moved to an RC-25 record-
ing chamber (Warner Instruments LLC) and perfused with 36 ± 1 °C
HEPES based solution (in mM): 137 NaCl, 5 KCl, 0.44 KH2PO4, 20
HEPES, 4.2 NaHCO3, 5 D-glucose, 2 CaCl2, 1.2 MgCl2 and 1 Na-pyruvate
with pH adjusted to 7.4 with NaOH. Ca2+-measurements were done
with an inverted IX71 microscope and UApo/340 ×20 air objective
(Olympus Corporation). Images were acquired with an ANDOR iXon
885 CCD camera (Andor Technology). A Polychrome V light source
(15 nm bandwidth) and the camera were synchronized by an external
DSP controller (TILL Photonics, Munich, Germany). TILLvisION software
was used to acquire image data (TILL Photonics). Fura-2 in spontane-
ously beating cells was exited at 340 nm and 380 nm light and emission
was detected at 505 nmand the data presented as ratios. The Ca2+ han-
dlingwas extracted for 15 s sweeps of spontaneous baseline beating and
categorized into different rhythm categories based on the types of ab-
normalities observed: normal beating with stable amplitude (N), ar-
rhythmias with double or more Ca2+ peaks (AD), and arrhythmiasFig. 1. Pluripotency of iPSC lines. A: All the iPSC lines formed colonies typical for pluripotent stem
(B) and endogenousmarkers for pluripotent state (Nanog, Sox2, Oct3/4 and Rex1) were expres
yotype. E: Immunocytochemistry demonstrated the expression of pluripotency markers. F: Ce
markers for the three germ layers was detected from EBs by RT-PCR.with small amplitude Ca2+ events between the stable amplitude Ca2+
spikes (AS). A criterion for the AD group was a Ca2+ spike with double
or several peaks which do not reach the baseline. For the AS group the
presence of a small amplitude Ca2+ event of at least 10% of the preced-
ing Ca2+ spike amplitude was required. Numbers (n) of CMs measured
were: for G589D speciﬁc cells the n = 87, for 7-2ANGmutated the n =
80, and for control CMs the n = 45.
2.11. Statistical analysis
The variance between two experiments or more was calculated in
Microcal Origin™ 9.0. Variance between two individual experiments
was accessed using the two sample t-test and between more than two
individual experiments the one-way ANOVA-test was used and follow-
ed by a Scheffe's post hoc-test. In drug experiments, the baseline and
drug effectwere compared using paired sample t-test. p b 0.05was con-
sidered signiﬁcantly different and levels of signiﬁcance are represented
as (*) p b 0.05 and (**) p b 0.01. Data is shown as mean ± S.E.M. if not
otherwise stated.
3. Results
3.1. Pluripotency of the iPSCs
All the iPSC lines used in this study were veriﬁed for their
pluripotency (control iPSCs have been characterized earlier [22]). Both
control and LQT1-speciﬁc lines formed colonies typical for human plurip-
otent stem cells (Fig. 1 A). The iPSCs also expressed markers for pluripo-
tent state shown both by RT-PCT and immunocytochemistry (Fig. 1 C
and E), and the transgenes were silenced (Fig. 1 B). In vitro pluripotency
was shownby embryoid body (EB) formation (Fig. 1G) and in vivoby ter-
atoma forming assay (Fig. 1 F). All the lineswere also veriﬁed for the nor-
mal karyotype (Fig. 1 D).
3.2. Biochemical and genetic analysis of iPSC derived CMs
The expression pattern of spontaneously single beating cells was typ-
ical for CMs exhibiting troponin T,α-actinin, myosin heavy chain (MHC),
atrial speciﬁc myosin light chain (MLC2a) and ventricular myosin light
chain (MLC2v). Fig. 2 A–Cdepicts representative immunostainings of con-
trol (Fig. 2 A), G589D (Fig. 2 B) and ivs7-2ANG (Fig. 2 C) speciﬁc cell lines.
The LQT1-speciﬁc lines were found to carry the correct mutations
and these mutations were not found in control lines. This was deter-
mined by RT-PCR analysis and restriction enzymedigestion (Fig. 2 D–F).
3.3. Mechanical properties of LQT1-speciﬁc CMs
We ﬁrst visually analyzed the beating behavior of single CMs in
videos obtained from the two control lines, the two G589D speciﬁc
lines and the two ivs7-2ANG speciﬁc lines. Control CMs used in the
video analysis had a normal beating pattern (marginal irregularities,
see below) with only contraction and relaxation phases following
each other. However, with our two G589D speciﬁc lines we also ob-
served a large proportion of abnormally beating cells with a prolonged
phase of contracted state before relaxation. The two ivs7-2ANG lines
were also having a prolonged contraction/relaxation cycle. These cells
typically had normal contraction but the relaxation phase was
prolonged having vacillation before cells fully relaxed (see Supplemen-
tary videos 1–3).cells. B and C: All the exogenous transgenes (Oct3/4, Sox2, Klf4 and c-Myc) were silenced
sed (C). β-Actinwas used as a housekeeping gene. D: All the iPS cell lines had normal kar-
ll types derived from all three germ layers were found in teratomas. G: The expression of
Fig. 2. Characterization of iPSC derived CMs. A–C: The CMs expressed cardiac-speciﬁc proteins. The scale bars refer to 100 μm. D–F: The LQT1-speciﬁc lines carried the correct mutations
while noG589D or ivs7-2ANGmutationswere found in control cell lines. “A” in theﬁgure refers toG589Dmutation and “B” to ivs7-2ANG. Control CMs produced products of 146 and 82 bp
(and 39 bp, not shown in the ﬁgure) for G589D, and 228 bp-product (also fragments of 39 and 33 bp, not shown in the ﬁgure) for the region corresponding ivs7-2ANGmutation (D). Het-
erozygous G589D speciﬁc lines (one shown in E) created an extra product of 185 bp and heterozygous ivs7-2ANG lines had an extra product with the size of 261 bp (one in F). G and H
illustrate the cleavage sites for the restriction enzymes used, their disappearance due to themutations and the sizes of the products from the reactions for G589D (G) and ivs7-2ANG (H).
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tionswere analyzed in detail according to the displacementmodel illus-
trated in Fig. 4 A (see also the Methods section). Representative signals
from single CMs from both LQT1-speciﬁc cell lines (G589D or ivs7-
2ANG) as well as from control CM are presented in Fig. 3 D–F. Normally
beating control CMs (n= 13) comprised only of the phases 1 (contrac-
tion), 3 (relaxation) and 5 (relaxed) (Fig. 4 B). However, in 17/24 CMs
with G589D mutation, a prolonged contraction time was observed:
They exhibited an additional phase 2 between contraction and relaxa-
tion phases, and during that phase the CMs stayed contracted. In a
minor proportion (2/17) of G589D-CMs, a phase 4 (incomplete relaxa-
tion)was also found (Table 1, Fig. 4 C). CMs carrying the ivs7-2ANGmu-
tation also exhibited a prolonged contraction (phase 2, in 17/25), but
the duration of the phase 2 was not as prominent as in G589D-CMs. In-
stead, ivs7-2ANG-CMs typically had rather normal contraction, but the
relaxation was abnormal and prolonged (in 15/17 CMs) due to vacilla-
tion (incomplete relaxation, phase 4, Table 1, Fig. 4 D). The time dura-
tions of different phases in control CMs and in CMs with the two LQT1
speciﬁc mutations are summarized in Table 1. There was some overlap
in the abnormal beating behavior between the two mutations: Howev-
er, only 12% (2/17) of the cells with G589D failed to relax normally, but
88% (15/17) of the cells with ivs7-2ANG demonstrated some prolonga-
tion in the contraction phase (phase 2). Beating patterns comparable to
controls were also observed in CMs with G589D (n = 7/24, 29%) or
ivs7-2ANG (n = 8/25, 32%).
When the absolute time of contraction (phases 1 and 2), relaxation
(phases 3 and 5) and incomplete relaxation (phase 4) was plotted
against the beating frequency the contraction time for the control cell
population (Fig. 4 E) stayed at the range of 0.25–0.5 s corresponding
the contraction time of human heart [27]. The relaxation time increased
with a decreased beating rate also resembling the behavior of human
heart. The abnormally beating LQT1-CMs presented contraction timesof up to 0.75 s, while the contraction times of the control cells were
less than 0.5 s (a not statistically signiﬁcant difference, one-way
ANOVA). If incomplete relaxation (phase 4) was added to the contrac-
tion time, the total times when the cells were not relaxed, were even
more different from the times observed in normally beating cells al-
though the difference was still not statistically signiﬁcant (Fig. 4 F and
G). The normally beating LQT1-CMs resembled control CMs regarding
their contraction-relaxation properties (Supplementary Fig. 1).
3.4. Allelic imbalance in patient speciﬁc cells
The allelic discriminations between the WT and mutated KCNQ1 al-
leles in CMs speciﬁc for either G589D or ivs7-2ANG mutation were de-
termined. The expression ratio between the WT and the G589D-
KCNQ1 was found to be 4:1 (WT:mutated) in both LQT1-G589D cell
lines (Supplementary Fig. 2). For the KCNQ1-ivs7-2ANG mutation the
discovered ratio was 3:1 (WT:mutated) (Supplementary Fig. 2).
3.5. Electrical properties of LQTS-speciﬁc CMs
3.5.1. Baseline characteristics
Representative APs from ventricular CMs (both G589D and ivs7-
2ANG-speciﬁc) as well as from control CM are presented in Fig. 3 G–I.
The majority of the CMs recordedwere ventricular-like and only amar-
ginal proportion was nodal-like (Table 2A). As expected, the APDswere
signiﬁcantly prolonged in nodal-, atrial- and ventricular-like LQT1-CMs
compared to the control CMs (Fig. 5 D, ANOVA, p b 0.05). MDPs for
atrial- and ventricular-like CMs were recorded from −65 mV to
−82 mV with overshoots of around +40 mV. In contrast, nodal-like
CMs were more depolarized and around −66 mV with overshoots
less than +25 mV (Table 2A).
Fig. 3. ECGs of the donors and functionality of iPSC derived CMs. A–C: ECGs from the primary cell donors. D–F: Video recording analysis of control (D), G589D (E) and ivs7-2ANG
(F)-speciﬁc CMs. Contraction is indicated with downward peak and the upward peak refers to relaxation. Bars (E) indicate the phase 2 (see Fig. 4 A) and show the time when the CMs
stayed contracted and the highlighted areas (F) refer to the time of incomplete relaxation (phase 4 in Fig. 4 A). G–I: Ventricular APs from control CMs (G) and LQT1-speciﬁc CMs carrying
G589D (H) or ivs7-2ANG (I). J–L: Ca2+-imaging signals from control (J) and LQT1-speciﬁc CMs (K, L). Themost prevalent type of abnormal Ca2+ transients in ivs7-2ANG-speciﬁc CMswas
additional small Ca2+ transients (AS) (L, extra peaks marked with arrows) but in G589D CMs double or more Ca2+ peaks (AD) (K) in addition to AS were seen.
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speciﬁc CMs, spontaneous baseline early afterdepolarizations (EADs)
were observed in 16.7% (5/30) of ventricular-like CMs (Fig. 5 E,
Table 2B). These CMs with baseline EADs were not used in the drug
studies. Nevertheless, in these cells with spontaneous EADs we found
a consistent elevation of the APD90/APD50 ratios (N1.8) compared to
baseline ratios without EADs (b1.3). The ratio prolongation is due to
the presence of EADs evoking around−25mV, and thereby prolonging
only the APD90 value (see Fig. 5 E).
3.5.2. Effect of JNJ303 and E-4031
Ventricular-like CMs were exposed to the IKs blocker, JNJ303
(300 nM) and APs from the baseline, in the presence of JNJ303 and
after wash out was extracted (Fig. 5 F). In control CMs (n = 10),
JNJ303 signiﬁcantly prolonged APD50 and APD90 by a similar proportion
of 31% and 28%, respectively, but other AP characteristicswere unaffect-
ed (Table 3A). However, the effect of JNJ303 was only marginal on the
APD50 and APD90 in G589D-speciﬁc cells (prolongation of 7.7% and
8.7%, respectively, Fig. 5 F, middle panel), and in ivs7-2ANG-speciﬁc
CMsnoeffectswere observed (Table 3A, Fig. 5 F, lower panel). The effect
of JNJ303 was fully reversible following the wash out, and the beating
frequency was not signiﬁcantly affected. In a few cells from each
group the JNJ303 block was veriﬁed by a consecutive application,
which always was similar to the ﬁrst (Fig. 5 F, LQT1-G589D). The
APD90/APD50 ratios for the control, G589D-speciﬁc- and ivs7-2ANG-
speciﬁc CMs at baselines and in the presence of JNJ303 were similar
and found to be between 1.19–1.27.
To evaluate our IKsﬁndingswe also applied the IKr (hERG) blocker, E-
4031 (100 nM) on ventricular-like CMs. The effect of E-4031 from threerepresentative current-clamp recordings is shown in Fig. 5 G. In control
cells the APD50 and APD90 were prolonged by E-4031 (30% and 74%, re-
spectively), and the APD90/APD50 ratio was now increased from 1.21
(baseline) to 1.67 (E-4031) but no EADs were evoked (Fig. 5 G, upper
panel, Table 3B). In contrast, all ventricular-like CMs in the G589D-
speciﬁc group (5 cells) and in the ivs7-2ANG-speciﬁc group (7 cells) ex-
hibited EADswhen exposed to E-4031 (Fig. 5 G,middle and lower panel,
respectively). The G589D-CMs had APD50 and APD90 signiﬁcantly
prolonged by 70% and 318% (paired sample t-test), respectively, and
ADP90/APD50 ratios were found to be increased from 1.16 (baseline) to
2.18 (E-4031). In the CMs with ivs7-2ANG, APD50 and APD90 were
even more signiﬁcantly prolonged by 412% and 771% (paired sample
t-test), respectively, and ADP90/APD50 ratios were found to be increased
from 1.14 (baseline) to 2.09 (E-4031). In contrast to the effects of
JNJ303, E-4031 decreased the beating frequency of all CMs (paired sam-
ple t-test). All CMs tested with E-4031 became signiﬁcantly depolarized
during exposure (paired sample t-test), but the overshoot (peak) was
not affected by E-4031 (Fig. 5 G, Table 3B). Even though APDs nearly re-
covered followingwash out the,MDPs recovered only partially (Fig. 5 G,
right panels) after exposure to E-4031. In line with this, the beating fre-
quency increased following the wash out (data not shown).
3.6. Comparison of the electrical and mechanical phenotypes
The mechanical analysis was also conducted together with the cur-
rent clamp-measurements (Fig. 6). Thereby themechanical and electro-
physiological phenotypes could be compared and the timing of the
electrical activity and the contraction/relaxation of the cells could be
evaluated. In both cell types, control CMs (Fig. 6 A) and LQT1 speciﬁc
Fig. 4. Analysis of LQT1-CMs using digital image correlation. A: An artiﬁcial illustration of a beating signal. 1: time of contraction (phase 1), 2: time in contracted state (phase 2), 3: time of
relaxation (phase 3), 4: time of incomplete relaxation (phase 4), and 5: time in relaxed state (phase 5) (see phases also in Table 1). The same colors and patterns are used in panels B–G.
B: Beating pattern of control CMs. C: Beating pattern of G589D-CMs. D: Beating pattern of ivs7-2ANG-CMs. The cells are presented in order of beating rate: control CMs: 12–66 beats/min,
G589D-CMs: 8–62 beats/min and ivs7-2ANG-CMs: 9–45 beats/min. E–G: The time duration from the beginning of contraction to the beginning of relaxation and from the beginning of
relaxation to the beginning of contraction are presented. Contraction time was in the range of 0.25–0.5 s in control CMs (E). In LQT1-CMs the contraction time was longer or incomplete
relaxation was present (F and G). The points for contraction time are enlarged to highlight the differences in the contraction times between control CMs and LQT1 speciﬁc CMs (a point
with a value of 1.75 ms in G589D-ﬁgure is not included).
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LQT1 speciﬁc CMs the APD was clearly prolonged and the mechanical
abnormality correlated nicely with this prolongation (Fig. 6 B). Also,
the mechanical activity of the LQT1 speciﬁc cells seemed to continue
longer after the electrical activity had already stopped when compared
to control CMs.
3.7. Ca2+ handling of LQT1-speciﬁc CMs
To further study the functionality of LQT1 speciﬁc CMs, Ca2+ tran-
sients were measured during spontaneous baseline beating. In G589D
and ivs7-2ANG speciﬁc as well as in controls three major responses
were found. A robust beating pattern with stable Ca2+ amplitude andfrequency were characteristic for the majority of the control CMs (N),
while arrhythmias with double or more Ca2+ peaks (AD) or arrhyth-
mias with small amplitude Ca2+ events between the stable amplitude
Ca2+ spikes (AS) were frequently seen in G589D and ivs7-2ANG CMs
(Fig. 7 A, Supplementary Table 1). Both types of arrhythmias (AD and
AS) were seen in all cell types though the Ca2+ transient abnormalities
were more prevalent in both LQT1 speciﬁc cell lines compared to con-
trol CMs (Fig. 7 B). The cells with G589D had the highest proportion of
ADs (23%). The duration of the calcium elevation was signiﬁcantly lon-
ger in CMs with G589D exhibiting ADs compared to those showing AS
type of arrhythmia or normal beating (p b 0.01, one-way ANOVA). AS-
arrhythmia were also more pronounced in CMs with G589D resulting
in signiﬁcantly lower beating frequency (p b 0.02, one-way ANOVA).
Table 1
The average times (ms) and standardmean errors for each individual beating phase and the total sum of the phases. Phase 1 is the time of contraction, phase 2 refers to the timewhen the
cells stay contracted, phase 3 is the relaxation time, and phase 4 indicates the time of incomplete relaxation. The timewhen the cells are relaxed (phase 5) is not displayed in the table. (*)
indicates p b 0.05 and (***) indicates p b 0.001 (one-way ANOVA) for abnormal G589D-CMs vs. control CMs and vs. abnormal ivs7-2A>G-CMs concerning the phase 2. For abnormal ivs7-
2A>G-CMsvs. abnormalG589D-CMs (two sample t-test) in the case of thephase 4 (*) also indicates p b 0.05 and (***) indicates p b 0.001. Data is presented asmean±S.E.M. The abnormal
behavior of the cells is highlighted with bold.
BPM Phase 1 Phase 2 Phase 3 Phase 4 Sum P 1–4
Control
Normal n = 11 29.3 ± 4.4** 294.3 ± 31.9 4.7 ± 1.9 426.0 ± 41.9 N/A 725.0 ± 70.2
Abnormal n = 0 N/A N/A N/A N/A N/A N/A
G589D
Normal n = 7 33.2 ± 6.5 275.9 ± 19.2 15.5 ± 5.7 362.0 ± 19.3 0.0 ± 0 653.4 ± 27.5
Abnormal n = 17 23.6 ± 3.6 285.2 ± 26.3 180.8 ± 28.8*
(n = 17/17)




Normal n = 8 30.6 ± 5.7 248.2 ± 31.1 5.0 ± 2.9 383.0 ± 48.0 0.0 ± 0 636.3 ± 79.0
Abnormal n = 17 25.2 ± 2.3 318.7 ± 39.9 46.3 ± 13.6
(n = 15/17)
424.8 ± 44.4 366.7 ± 66.9***
(n = 17/17)
1156.4 ± 123.0
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cell lines (G589D or ivs7-2ANG) as well as from control CM are shown
in Fig. 3 J–L.
4. Discussion
In the present study we analyzed LQT1-speciﬁc CMs carrying either
G589D or ivs7-2ANG mutation in the KCNQ1 gene. The LQT1-CMs with
either mutation had prolonged AP durations. EADs were spontaneously
present only in CMs with G589Dmutation but not with ivs7-2ANGmu-
tation. However, EADs could be evoked pharmacologically in CMs with
either mutation. In control CMs EADs were absent at baseline and they
could not be induced with IKs or IKr blockers. Ca2+ transients were
also aberrant in both types (G589D and ivs7-2ANG) of LQT1-CMshaving
large double spikes or extra spikeswith small amplitude. In control CMs
contraction and relaxation happened fast with no pause in-between.
However, this beating behavior in LQT1-CMs was clearly abnormal.
Using video recording analysis, LQT1-speciﬁc CMswere found to exhibit
two distinct forms of abnormal mechanical beating behavior: CMs car-
rying G589D mutation typically stayed contracted for prolonged time
while CMs with ivs7-2ANG mutation showed an incomplete relaxation
phase.
Our current clamp data demonstrates that the APDs measured from
LQT1-CMswith either of themutations (G589D or ivs7-2ANG)were sig-
niﬁcantly prolonged. Heterozygous expression of the G589D and ivs7-
2ANGmutations in non-cardiac cells has earlier shown that both muta-
tions have a dominant negative effect in gene expression systems [7,28],
although the expression of G589Dmutation did not lead to altered cur-
rent density, the cAMP induced up-regulation of IKs was abolished byTable 2A
Baseline characteristics of spontaneous action potentials (APs) from control cardiomyocytes (C
icance levels of p b 0.05 and (**) p b 0.01. Signiﬁcance levels were obtained by one-way ANOVA






Nodal-like 2 (6.7) 75.7 ± 4.4 104.4 ± 2.1
Atrial-like 4 (13.3) 61.5 ± 8.5 132.6 ± 13.6
Ventricular-like 24 (80.0) 55.6 ± 3.4 291.8 ± 21.5
LQT1 (G589D)
Nodal-like 2 (5.1) 54.5 ± 4.1 164.5 ± 6.2*
Atrial-like 12 (30.8) 38.9 ± 4.5 335.7 ± 36.2**
Ventricular-like 25 (64.1) 37.7 ± 4.6* 458.5 ± 57.4**
LQT1 (ivs7-2ANG)
Nodal-like 2 (6.1) 69.4 ± 6.0 170.5 ± 17.3
Atrial-like 6 (18.2) 50.9 ± 9.9 187.8 ± 15.0*
Ventricular-like 25 (75.7) 45.6 ± 2.8* 416.1 ± 22.1**the mutation [28]. The ivs7-2ANG mutation on the other hand, almost
completely abolished the IKs current when transiently expressed in
non-cardiac cells [7]. The lack of IKs reduction in the G589D transfected
non-cardiac cells may be due to trafﬁcking problems caused by G589D:
the mutated protein does not reach the cell surface [9]. The effect of
G589D in LQTS has also been explained by disrupted β-adrenergic acti-
vation of IKs [29] but this study clearly shows that the disease phenotype
caused byG589D is not solely dependent on central nervous system and
activation of β-adrenergic receptor since it is present also in single dis-
sociated CMs.
As mentioned, baseline-APDs were signiﬁcantly prolonged in LQT1-
CMs compared to the control CMs.With LQT1-CMwe could further de-
tect that ventricular-like CMs were only marginally affected or
completely unaffected by IKs blockage. The lack of effect of IKs blockade
in our LQT1-CMs is in accordance with the previous observation that
the baseline IKs current is decreased by about 75% in LQT1-CMs [18].
In our study, G589D-CMs had longer baseline-APD90 than ivs7-2ANG-
CMs and spontaneous EADs were observed only in G589D-CMs, but
none in CMswith ivs7-2ANG nor in control CMs. However, the APD pro-
longation with IKr blockage always evoked EADs in both types of LQT1-
speciﬁc CMs but not in control CMs. The IKr block also induced a depolar-
ization of the baseline as previously shown [30].
CMs carrying either one of the LQT1mutations demonstrated abnor-
malities in intracellular Ca2+ transients, but the abnormal featureswere
more common in G589Dmutated CMs similarly as these CMs hadmore
severe abnormalities in current clamp analysis. Abnormal Ca2+ tran-
sients could be occasionally observed also in control CMs (6% of the
cells), but at least third of the LQT1-CMs presented Ca2+ abnormalities.
In LQTS-CMs, EADs have been thought to result from late membrane-Ms) as well as from LQT1-G589D- and LQT1-ivs7-2ANG-speciﬁc CMs. (*) indicates signif-









159.1 ± 0.4 88.7 ± 0.6 −66.0 ± 0.3 8.70 ± 2.3
189.1 ± 32.2 100.4 ± 3.0 −71.6 ± 3.4 26.1 ± 17.9
349.6 ± 22.9 110.2 ± 2.4 −69.6 ± 1.5 19.5 ± 4.7
309.2 ± 39.7* 83.4 ± 3.7 −63.6 ± 1.7 4.2 ± 7.1
477.7 ± 51.4** 106.4 ± 2.8 −70.5 ± 2.0 23.9 ± 6.9
545.3 ± 62.6** 109.0 ± 3.1 −73.6 ± 1.6 14.8 ± 1.8
232.1 ± 7.7* 93.0 ± 1.3 −61.0 ± 9.6 9.5 ± 1.5
287.8 ± 18.5* 101.2 ± 2.2 −66.0 ± 2.6 16.3 ± 4.2
481.5 ± 23.6** 115.1 ± 1.3 −72.3 ± 1.0 16.2 ± 2.4
Fig. 5. Current clamp-recordings from control and LQT1-CMs carrying either G589D or ivs7-2ANG. Beating CMs un-patched (A), patched in relaxed phase (B), and patched in contracted
phase (C). Arrows indicate the positions where the contraction can be seen (C). D: Current clamp-recordings of ventricular-, atrial- and nodal-like APs are depicted for control (upper
panel), G589D (middle panel) and ivs7-2ANG (lower panel)-CMs. E: Baseline characteristics of spontaneous APs with early after depolarizations (EADs) in G589D-speciﬁc CMs: dashed
line represents 0 mV and arrows indicate EADs. The effects of JNJ303 (F), and E-4031 (G) are shown for ventricular-like AP recordings from controls, as well as from G589D and ivs7-
2ANG-CMs. Baseline (1), (2) effect of IKs (JNJ303) or IKs (E-4031) blocker, and (3) wash out measurement which fully recovers the effect of JNJ303 but only partially reverses the baseline
AP characteristics after the E-4031 treatment. Arrows indicate EADs. The right panels show the time courses for the overshoot (Max), MDP, APD90 and APD50. Marks (1), (2) and (3) in-
dicate the times of AP extraction, and the bar represents the exposure of the cells for JNJ303 or E-4031.
Table 2B














Ventricular-like 5 30.1 ± 4.4 820.3 ± 93.1 1559.6 ± 407.1 112.8 ± 3.8 −71.5 ± 2.7 12.7 ± 2.3
28 A.L. Kiviaho et al. / IJC Heart & Vasculature 8 (2015) 19–31inward currents, such as the spontaneous reactivation of the L-type
Ca2+-channel during prolonged action potential duration [31]. There-
fore it can be assumed that abnormalities in Ca2+ transients shown inTable 3A






Baseline 10 48.3 ± 8.4 264.7 ± 47.0
300 nM JNJ303 42.8 ± 7.6* 346.6 ± 68.0**
LQT1 (G589D)
Baseline 9 44.7 ± 5.5 393.0 ± 57.8
300 nM JNJ303 38.7 ± 5.2 423.6 ± 64.4
LQT1 (ivs7-2ANG)
Baseline 6 44.5 ± 3.2 387.0 ± 49.3
300 nM JNJ303 43.1 ± 4.6 386.0 ± 36.0this study may correspond to EADs and lead to severe arrhythmias. A
similar ﬁnding has been also earlier observed and demonstrated com-









334.0 ± 30.1 103.6 ± 3.9 −69.0 ± 2.5 25.3 ± 10.4
428.2 ± 79.9** 106.3 ± 4.6 −69.7 ± 2.6 27.8 ± 12.3
500.4 ± 76.0 108.3 ± 3.1 −71.9 ± 2.6 11.6 ± 2.6
544.0 ± 86.0 106.9 ± 2.8 −70.8 ± 2.3 10.9 ± 2.1
458.1 ± 51.6 112.4 ± 4.2 −74.2 ± 2.6 9.8 ± 1.9
452.0 ± 37.9 111.1 ± 3.6 −72.0 ± 3.1 9.8 ± 1.9
Table 3B
Effect of IKr block on ventricular-like CMs. Ventricular-like LQT1-speciﬁc CMs all showed early after-depolarizations (EADs) in the presence of E-4031. Statistical difference of paired sample














Baseline 5 68.8 ± 4.3 256.8 ± 30.4 308.0 ± 30.1 111.4 ± 3.5 −74.6 ± 3.6 10.1 ± 1.4
100 nM E-4031 60.2 ± 7.6 332.4 ± 82.5 535.3 ± 102.9* 83.3 ± 7.5** −52.1 ± 1.5** 6.2 ± 1.8
LQT1 (G589D)+EADs
Baseline 5 43.2 ± 3.5 458.6 ± 25.1 536.0 ± 33.8 114.6 ± 0.4 −81.1 ± 0.9 13.7 ± 2.9
100 nM E-4031 23.5 ± 4.4* 781.7 ± 16.2*** 1703.8 ± 100.8** 103.6 ± 1.7* −70.7 ± 2.9* 9.3 ± 1.5*
LQT1 (ivs7-2ANG)+EADs
Baseline 7 42.5 ± 3.4 464.7 ± 49.3 526.1 ± 53.6 117.5 ± 1.4 −73.6 ± 1.8 14.1 ± 0.9
100 nM E-4031 13.8 ± 2.6*** 1915.7 ± 468.8* 4055.8 ± 1173.1* 109.7 ± 2.6** −64.1 ± 2.7** 11.3 ± 1.0**
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served in our study and their correlation with the EADs as well as with
the motion abnormalities observed with the two different LQT1 related
mutations.
In addition to conventional methods (patch clamp and Ca2+-imag-
ing), we also analyzed the mechanical beating behavior of single
LQT1-speciﬁc CMs by video imaging and this analysis revealed either
prolonged contraction (G589D) or disturbed relaxation (ivs7-2ANG) of
the cells. This abnormality has not been reported earlier in iPSC-
derived LQTS speciﬁc CMs, but the observation is in line with a clinical
observation of prolonged contraction duration in LQTS mutation car-
riers compared to healthy individuals [33]. In this study, combined cur-
rent clamp-measurements and video analysis of the mechanical
behavior demonstrated the correlation between the prolonged APD
and abnormal mechanical phenotype also in single LQT1 speciﬁc CMs.Fig. 6. Combined current clamp-measurements and video analysis. Control CMs (A) aswell as th
Contraction followed immediately after the initiation of AP. In LQT1 speciﬁc CMs theAPDwas cl
video analysis correlated with the prolongation of the APD (B).The two patients of this study are both heterozygous for the LQT1-
mutations and the allelic discrimination study revealed an imbalance
in the expression of the WT and mutated forms of KCNQ1. The ratio of
expression (WT:mutated) for G589D was found to be 4:1 and for ivs7-
2ANG the ratio was 3:1. It was reported earlier that LQT1-CMs with
R190Qmutation exhibited equal expression of wild type andmutant al-
leles [18]. With the expression ratios observed in our study, the proba-
bility that one or more mutated α-subunits are participating in
forming the tetrameric IKs channel is about 70%. This is in accordance
with the functional abnormalities observed in the videos recorded
from our CMs. Ca2+-imaging also revealed abnormal Ca2+ transients
in LQT1 CMs but the proportions of abnormal CMs were slightly lower
than those obtained with video imaging. The presence of spontaneous
EADs were, however, considerably lower than other abnormalities. It
is possible that there are compensatory mechanisms involved ine LQT1 speciﬁc CMs (B) showed a nice correlation in timing of the contraction and the AP:
early prolonged compared to the control cells and themechanical abnormality observed by
Fig. 7.Analysis of Ca2+ transients of control and LQT1 speciﬁc CMs. (A) Three different transient categories: normal transientswith stable amplitude (N), arrhythmiaswith double ormore
Ca2+ peaks (AD), and small amplitude Ca2+ events (arrows) (AS) were found. (B) Doughnut charts indicate the percentage of the control and LQT1 speciﬁc CMs under each transient
category (N, AD and AS).
30 A.L. Kiviaho et al. / IJC Heart & Vasculature 8 (2015) 19–31electrical data obtained by patch clamp, resulting in a lower frequency
of abnormalities compared to other methods. It is also important to
point out that the ratios obtained by allelic imbalancemeasurements re-
ﬂect the situation at mRNA level and do not accurately depict the pro-
portions of the two alleles expressed at protein level since the
transcripts may be alternatively processed before translation into pro-
teins. Further, there is a possibility that the expression ratio of the WT
and mutated allele may vary from cell to cell. It is also possible that
the cells with different beating properties could represent also a partic-
ular CM subpopulation (ventricular, atrial or nodal).
Our ﬁndings support the previous studies [4,6] suggesting that mu-
tations in different parts of theKCNQ1 gene are associatedwith different
clinical outcomes. However, no clinically distinct differences between
the patient groups carrying the two mutations presented in this study
have been reported. QTc of G589D-carriers has been reported to be
462 ± 38 if recorded from patients without any medication at the
time of ECG recording. For the ivs7-2ANG the corresponding QTc value
has been reported to be 470 ± 31 [21]. Both patients investigated
here were symptomatic. G589D-patient, 46-year-old female has been
suffering from syncopal spells. The other patient, 51-year-old female
carrying ivs7-2ANG in KCNQ1, has suffered from dizziness, darkening
of vision and more recently also from episodes of unconsciousness. On
cell level G589D-CMs demonstrated more severely prolonged APDs
which could be visualized as prolonged contracted state in beating
CMs. The ivs7-2ANG-CMs had less severe APD prolongation at baseline,
but theyweremore sensitive to agents blocking other ion channels. Ad-
ditionally their beating behavior presented problems in relaxation
phase suggesting other, currently unknown problems in repolarization
currents in these cells. Since the patients present clinically similar phe-
notypes, it is most likely that there are some compensatory elements
inﬂuencing the intact heart which moderate the clinical outcome. The
highly organized transverse (t)-tubule structures in ventricularmyocar-
diummight partially balance the abnormalities in the Ca2+ transients of
G589Dand ivs7-2ANG-CMs [34]. At the same time, it is also possible that
the typical abnormality that we observed in G589D-cells, namely
prolonged contraction time, could actually generate more severe symp-
toms due to a shortened relaxation time.This is the ﬁrst time that two different LQTS relatedmutations in the
same gene are reported to result in differences in functional properties
of the patient speciﬁc CMs. Additionally, this is the ﬁrst report to dem-
onstrate abnormal mechanical beating properties of LQTS-speciﬁc sin-
gle CMs. Earlier, the mechanical abnormalities with increased diastolic
phase have been reported at the level of a whole heart of LQTS patients
[33] but the abnormal mechanical phenotype in LQTS speciﬁc single
cells is a novel and rather unexpected ﬁnding. Here we demonstrate
that the disease speciﬁc beating of the cells can be distinguished from
the normal behavior of single CMs just by analyzing themechanical fea-
tures of the beating. This novel method for characterization of CMsmay
generate additional detailed information from the beating of the cells
and also from LQTS in general. In addition, this simple detectionmethod
allows developing it further for high through-put screening for LQTS
speciﬁc – and also other cardiac disease speciﬁc – CMs.5. Conclusion
CMs derived from two symptomatic LQT1 patients carrying two dif-
ferent KCNQ1mutations presented different manifestations when their
electrical or mechanical beating properties were analyzed. APDs were
signiﬁcantly prolonged in both types of LQT1-CMs, but spontaneous
EADs were present only in G589D-CMs. Mechanical beating behavior
of G589D-CMs presented mostly prolonged contraction phase while
inv7-2ANG-CMs had a fairly normal contraction time, but failed to
relax properly. These results also demonstrate that simply by analyzing
the mechanical beating behavior of the cells, the diseased CMs can be
distinguished from the normal ones, providing a simple platform for di-
agnostic applications using iPSC derived CMs in the future.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ijcha.2015.04.008.Conﬂicts of interest
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